Literature DB >> 11308260

Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling?

G P Skliris1, P J Carder, M R Lansdown, V Speirs.   

Abstract

Oestrogen receptor (ER) is used routinely to predict endocrine responsiveness in patients with breast cancer. A second ER, ERbeta has been described but its significance remains undefined; most studies have described mRNA levels rather than protein expression. Here, we demonstrate for the first time, immunohistochemical detection of ERbeta in archival breast tumours. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11308260      PMCID： PMC2363860          DOI： 10.1054/bjoc.2001.1721

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  13 in total

1.  Immunolocalisation of oestrogen receptor beta in human tissues.

Authors:  A H Taylor; F Al-Azzawi
Journal:  J Mol Endocrinol       Date:  2000-02       Impact factor: 5.098

2.  Cloning of a novel receptor expressed in rat prostate and ovary.

Authors:  G G Kuiper; E Enmark; M Pelto-Huikko; S Nilsson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

Authors:  K Paech; P Webb; G G Kuiper; S Nilsson; J Gustafsson; P J Kushner; T S Scanlan
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

4.  Identification of wild-type and exon 5 deletion variants of estrogen receptor beta in normal human mammary gland.

Authors:  V Speirs; I P Adams; D S Walton; S L Atkin
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

5.  Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.

Authors:  T A Järvinen; M Pelto-Huikko; K Holli; J Isola
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

6.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A.

Authors:  S Green; P Walter; V Kumar; A Krust; J M Bornert; P Argos; P Chambon
Journal:  Nature       Date:  1986 Mar 13-19       Impact factor: 49.962

7.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

8.  Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients.

Authors:  V Speirs; C Malone; D S Walton; M J Kerin; S L Atkin
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

Review 9.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

Authors:  D C Allred; J M Harvey; M Berardo; G M Clark
Journal:  Mod Pathol       Date:  1998-02       Impact factor: 7.842

10.  Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis.

Authors:  E Leygue; H Dotzlaw; P H Watson; L C Murphy
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701
View more
  24 in total

1.  Distinct expression patterns of ER alpha and ER beta in normal human mammary gland.

Authors:  V Speirs; G P Skliris; S E Burdall; P J Carder
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

2.  Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues.

Authors:  John R Hawse; Jodi M Carter; Kirsten G M Aspros; Elizabeth S Bruinsma; Justin W Koepplin; Vivian Negron; Malayannan Subramaniam; James N Ingle; Karen L Rech; Matthew P Goetz
Journal:  Breast Cancer Res Treat       Date:  2019-09-30       Impact factor: 4.872

3.  Potential clinical significance of ERβ ON promoter methylation in sporadic breast cancer.

Authors:  Ana Božović; Milan Markićević; Bogomir Dimitrijević; Snežana Jovanović Ćupić; Milena Krajnović; Silvana Lukić; Vesna Mandušić
Journal:  Med Oncol       Date:  2013-06-22       Impact factor: 3.064

Review 4.  Estrogen receptor-beta and breast cancer: translating biology into clinical practice.

Authors:  Yuet-Kin Leung; Ming-Tsung Lee; Hung-Ming Lam; Pheruza Tarapore; Shuk-Mei Ho
Journal:  Steroids       Date:  2012-03-29       Impact factor: 2.668

5.  FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.

Authors:  Takashi Shigekawa; Nobuhiro Ijichi; Kazuhiro Ikeda; Kuniko Horie-Inoue; Chikako Shimizu; Shigehira Saji; Kenjiro Aogi; Hitoshi Tsuda; Akihiko Osaki; Toshiaki Saeki; Satoshi Inoue
Journal:  Horm Cancer       Date:  2011-10       Impact factor: 3.869

6.  The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.

Authors:  L Nakopoulou; A C Lazaris; E G Panayotopoulou; I Giannopoulou; N Givalos; S Markaki; A Keramopoulos
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

7.  Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.

Authors:  Maria G Raso; Carmen Behrens; Matthew H Herynk; Suyu Liu; Ludmila Prudkin; Natalie C Ozburn; Denise M Woods; Ximing Tang; Reza J Mehran; Cesar Moran; J Jack Lee; Ignacio I Wistuba
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

8.  Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.

Authors:  Jonathan D Marotti; Laura C Collins; Rong Hu; Rulla M Tamimi
Journal:  Mod Pathol       Date:  2009-11-06       Impact factor: 7.842

9.  Photoperiod affects estrogen receptor alpha, estrogen receptor beta and aggressive behavior.

Authors:  Brian C Trainor; Michael R Rowland; Randy J Nelson
Journal:  Eur J Neurosci       Date:  2007-07       Impact factor: 3.386

10.  PAR1 is selectively over expressed in high grade breast cancer patients: a cohort study.

Authors:  Norma A Hernández; Elma Correa; Esther P Avila; Teresa A Vela; Víctor M Pérez
Journal:  J Transl Med       Date:  2009-06-18       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.